SUSTAINABILITY

CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY

Baumann Medical

CREATING VALUE – SUSTAINABLE APPROACHES FOR THE MEDICAL DEVICE INDUSTRY

David Pircher provides insights from a sustainability journey, showcasing what suppliers can contribute and how innovation and partnership support a common vision. The article outlines where the industry stands and why sustainability is a top priority, with concrete examples.

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

FROM VISION TO VICTORY: BUILDING A HANDS-ON ESG FRAMEWORK

Herman Rusch and Steven van Voorst discuss the steps that IGS GeboJagema has taken to provide its ESG efforts with a robust structure to build on and how doing so has made those efforts more effective and provided the company with clear, meaningful and measurable targets to work towards.

SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO

SUSTAINABLE DESIGN FOR HEALTHCARE DEVICES: PATHWAYS TOWARDS NET ZERO

Will Davies and Holly Milston consider sustainable pathways towards circularity in the medical device industry.

INTERVIEW: THE BENEFITS OF BEING AN EARLY ADOPTER OF SUSTAINABILITY PRINCIPLES

INTERVIEW: THE BENEFITS OF BEING AN EARLY ADOPTER OF SUSTAINABILITY PRINCIPLES

Reto Jost and Gabriel Kalbermatter talk exclusively with ONdrugDelivery's Guy Furness, discussing the progress Ypsomed has made in advancing its sustainability agenda, particularly the implementation of its ecodesign guideline, the benefits of being an early adopter of sustainability principles, how YpsoMate 5.5 mL has been designed from the ground up with sustainability in mind and where sustainability considerations currently fit into the wider pharma industry.

DESIGN FOR SUSTAINABILITY – THE CONSIDERATIONS BROUGHT TO LIFE

DESIGN FOR SUSTAINABILITY – THE CONSIDERATIONS BROUGHT TO LIFE

Oli Gould explores the use of lifecycle assessment in product design for sustainability to impact the environment positively.

INTERVIEW with Dora Rio, Head of Sustainability, SHL Medical

INTERVIEW with Dora Rio, Head of Sustainability, SHL Medical

Dora Rio discusses various aspects of SHL's approach to sustainability, including how it interacts with other players up and down the value chain, whether reusable or single-use devices are more sustainable and how SHL addresses sustainability concerns beyond CO₂.

SUSTAINABLE BY DESIGN: DEVELOPING PATIENT- AND PLANET-CENTRIC MEDICAL DEVICES

SUSTAINABLE BY DESIGN: DEVELOPING PATIENT- AND PLANET-CENTRIC MEDICAL DEVICES

Su Osorio, Stephanie Mou and Charlie Dean, explore the delicate balance between patient and planet centricity and propose a user- and planet-centric approach for the development of sustainable medical devices.

TOWARDS A COMPREHENSIVE SUSTAINABILITY STRATEGY

Dr Marie-Christine Klein

TOWARDS A COMPREHENSIVE SUSTAINABILITY STRATEGY

Marie-Christine Klein and Christian Weyler, look at the evolution of the company’s sustainability strategy within its regulatory and economic framework – and what decarbonisation means for the pharmaceutical industry.

SUSTAINABILITY PROGRAMMES: EVERY STEP COUNTS

SUSTAINABILITY PROGRAMMES: EVERY STEP COUNTS

Henryk Badack shares insights into the current state of sustainability in the pharma and biotech industry, how sustainability commitments vary between organisations and what companies can do to develop sustainability strategies that will last.

PCI’S ESG JOURNEY – ESTABLISHING PROCESSES AND DRIVING RESULTS

Gigi Bat-Erdene

PCI Pharma Services

PCI’S ESG JOURNEY – ESTABLISHING PROCESSES AND DRIVING RESULTS

Gigi Bat-Edene discusses the steps that PCI has taken towards realising its environmental, social and governance targets and achieving reductions in its greenhouse gas emissions in the journey towards net zero.

NAVIGATING THE TRANSITION TO SUSTAINABLE MEDICAL PROPELLANTS

Dr Timothy Noakes

NAVIGATING THE TRANSITION TO SUSTAINABLE MEDICAL PROPELLANTS

Timothy Noakes, Sheryl Johnson and Richard Greenhough, discuss the status of the current move from high-global-warming-potential propellants for pressurised metered dose inhalers to more sustainable alternatives.

OPTIMISING LOW-GWP pMDI SPRAYS FOR ENHANCED PERFORMANCE AND SUSTAINABILITY

Dr Benjamin Myatt

OPTIMISING LOW-GWP pMDI SPRAYS FOR ENHANCED PERFORMANCE AND SUSTAINABILITY

Benjamin Myatt and Daniel Duke explore the low-global-warming-potential propellants available and their implications for the performance of pressurised metered dose inhalers.

CHANGE IS IN THE AIR: THE FUTURE CLIMATE OF INHALED MEDICATION

Pauline Janssen

CHANGE IS IN THE AIR: THE FUTURE CLIMATE OF INHALED MEDICATION

Pauline Janssen, discusses the various available devices for pulmonary delivery of medications, with a deeper dive into the challenges presented by replacing pMDI propellants with high global warming potential with new alternatives, or whether the optimal solution could be phasing out pMDIs in favour of DPIs.

PHARMACEUTICAL INDUSTRY SUSTAINABILITY TARGETS, ONE YEAR ON

Catriona Eldridge

PHARMACEUTICAL INDUSTRY SUSTAINABILITY TARGETS, ONE YEAR ON

Catriona Eldridge, analyses whether the pharmaceutical industry is meeting its targets and doing enough in the fight against climate change.

REUSABLE VERSUS SINGLE-USE DEVICES: TRADE-OFFS IN IMPROVING SUSTAINABILITY

Alastair Willoughby

REUSABLE VERSUS SINGLE-USE DEVICES: TRADE-OFFS IN IMPROVING SUSTAINABILITY

Alastair Willoughby and Prem-Sagar Tank, explore various device trade-offs for both sustainability and cost in reusable injection devices, and consider how this compares with single-use devices.

LEVERAGING AI & BIG DATA FOR ECO-DESIGN COLLABORATION IN PHARMA

LEVERAGING AI & BIG DATA FOR ECO-DESIGN COLLABORATION IN PHARMA

Alissa Monk, Kami Krista, Cédric Montagnetegy and Carole Schanté, explore the potential of artificial intelligence and big data in eco-design with the aim of transforming the pharmaceutical industry towards greater sustainability.

SCALING GLP-1 DRUGS WITHOUT A MOUNTAIN OF WASTE

SCALING GLP-1 DRUGS WITHOUT A MOUNTAIN OF WASTE

Matt Parker, Simon Lyons and Alex Lyness, look at how the continued success of glucagon-like peptide-1 drugs is bringing into focus the need for environmentally sustainable self-injection systems. They discuss whether reloadable autoinjectors could be the way to boost sustainability, lower cost per dose, and match the scale and rate of adoption of these new therapies.

SOFT MIST INHALERS VERSUS NEBULISERS: DELIVERY EQUIVALENCE & FUTURE THERAPIES

SOFT MIST INHALERS VERSUS NEBULISERS: DELIVERY EQUIVALENCE & FUTURE THERAPIES

Zaid Aqrawe, Philippe Rogueda, Darragh Murnane and Bryan Eng, discuss the opportunity presented by soft mist inhalers as an alternative delivery device to nebulisers for inhaled therapies, contrasting the two device categories across multiple factors.

ADVANCING PHARMACEUTICAL CONTACT APPLICATIONS WITH PEEK: MEETING INCREASING DEMANDS

INDUSTRIALISATION

Marcus Jarman-Smith

ADVANCING PHARMACEUTICAL CONTACT APPLICATIONS WITH PEEK: MEETING INCREASING DEMANDS

Marcus Jarman-Smith and Yann Tréguier, discuss the myriad benefits that Victrex’s pharmaceutical-grade PEEK can offer to the drug delivery sector as a material of construction due to its versatile material properties.

PRACTICAL PATHWAYS TO SUSTAINABILITY

PRACTICAL PATHWAYS TO SUSTAINABILITY

Alex Fong and Olivia Houselander discuss the importance of sustainability in the healthcare sector and the challenges that must be overcome to achieve it in a meaningful and lasting way.

AN ECO-FRIENDLY AND ECONOMICAL APPROACH TO AUTOINJECTORS

John Palmer-Felgate

AN ECO-FRIENDLY AND ECONOMICAL APPROACH TO AUTOINJECTORS

John Palmer-Felgate introduces Eco-inject's patented innovation – a single-use, two-step autoinjector that is both eco-friendly and economical.

INTERVIEW: RDD EUROPE 2023 REVIEW & RDD 2024 PREVIEW

CONFERENCE SHOWCASE

INTERVIEW: RDD EUROPE 2023 REVIEW & RDD 2024 PREVIEW

Respiratory Drug Delivery talks with ONdrugDelivery, reviewing highlights of the successful RDD Europe 2023 event, which took place in Antibes, France last May, then describing what’s ahead for RDD 2024, which will take place in Tuscon, AZ, US, next May, including some of the key upcoming deadlines for participants.

EXPLORING THE PERFORMANCE OF LOW-GWP PROPELLANTS

Proveris Scientific

EXPLORING THE PERFORMANCE OF LOW-GWP PROPELLANTS

Grant Thurston and Lynn Jordan discusses the performance of pressurised metered dose inhaler propellants with a low global warming potential.

TRANSFORMING PHARMA MANUFACTURING TO DRIVE SUSTAINABILITY AND COST EFFICIENCY

TRANSFORMING PHARMA MANUFACTURING TO DRIVE SUSTAINABILITY AND COST EFFICIENCY

Michael Astle, Gareth Jenkins and Edward Mayo explore current strategies to reduce carbon emissions and drive cost efficiency throughout the healthcare industry.

Prev
1
2
3
4
5
…
7
Next

Top